Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation

Journal of Neurochemistry

Volumn 125, Issue 4, 2013, Pages 555-565

  Howard, Christopher D ^a   Pastuzyn, Elissa D ^b   Barker Haliski, Melissa L ^c   Garris, Paul A ^a   Keefe, Kristen A ^b,c  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Arc; dopamine; methamphetamine; preprotachykinin; striatum; zif268

Indexed keywords

DOPAMINE; MESSENGER RNA; METHAMPHETAMINE; PREPROTACHYKININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ARC GENE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; DENERVATION; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; EFFERENT NERVE; FLUORESCENCE IN SITU HYBRIDIZATION; FOREBRAIN; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HISTOCHEMISTRY; IMAGE ANALYSIS; IMMEDIATE EARLY GENE; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ZIF268 GENE;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; CYTOSKELETAL PROTEINS; DENERVATION; DOPAMINE; DOPAMINERGIC NEURONS; EARLY GROWTH RESPONSE PROTEIN 1; ELECTRIC STIMULATION; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; MALE; MEDIAL FOREBRAIN BUNDLE; METHAMPHETAMINE; NERVE TISSUE PROTEINS; NEUROTOXICITY SYNDROMES; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TACHYKININS;

RATTUS;

EID: 84876812653     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12234     Document Type: Article

References (72)

1. Abbruzzese G., Trompetto C., and, Marinelli L., (2009) The rationale for motor learning in Parkinson's disease. Eur. J. Phys. Rehab. Med. 45, 209-214.
2. Abercrombie E. D., Bonatz A. E., and, Zigmond M. J., (1990) Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine- treated rats. Brain Res. 525, 36-44.
3. Barker-Haliski M. L., Oldenburger K., and, Keefe K. A., (2012a) Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine. J. Neurochem. 123, 845-855.
4. Barker-Haliski M. L., Pastuzyn E. D., and, Keefe K. A., (2012b) Expression of the core exon-junction complex factor eukaryotic initiation factor 4A3 is increased during spatial exploration and striatally-mediated learning. Neuroscience 226, 51-61.
5. Bergstrom B. P., and, Garris P. A., (2003) "Passive stabilization" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J. Neurochem. 87, 1224-1236.
6. Boja J. W., Mitchell W. M., Patel A., Kopajtic T. A., Carroll F. I., Lewin A. H., Abraham P., and, Kuhar M. J., (1992) High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12, 27-36.
7. Brady K. T., Gray K. M., and, Tolliver B. K., (2011) Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol. Biochem. Behav. 99, 285-294.
8. Brown L. L., Schneider J. S., and, Lidsky T. I., (1997) Sensory and cognitive functions of the basal ganglia. Curr. Opin. Neurobiol. 7, 157-163.
9. Cahill P. S., Walker Q. D., Finnegan J. M., Mickelson G. E., Travis E. R., and, Wightman R. M., (1996) Microelectrodes for the measurement of catecholamines in biological systems. Anal. Chem. 68, 3180-3186.
10. Callaghan R. C., Cunningham J. K., Sykes J., and, Kish S. J., (2012) Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend. 120, 35-40.
11. Cass W. A., and, Manning M. W., (1999) Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J. Neurosci. 19, 7653-7660.
12. Castaneda E., Whishaw I. Q., and, Robinson T. E., (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J. Neurosci. 10, 1847-1854.
13. Chapman D. E., Hanson G. R., Kesner R. P., and, Keefe K. A., (2001) Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J. Pharmacol. Exp. Ther. 296, 520-527.
14. Chergui K., Svenningsson P., Nomikos G. G., Gonon F., Fredholm B. B., and, Svennson T. H., (1997) Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. Eur. J. Neurosci. 9, 2370-2382.
15. Daberkow D. P., Kesner R. P., and, Keefe K. A., (2005) Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning. Pharmacol. Biochem. Behav. 81, 198-204.
16. Daberkow D. P., Riedy M. D., Kesner R. P., and, Keefe K. A., (2007) Arc mRNA induction in striatal efferent neurons associated with response learning. Eur. J. Neurosci. 26, 228-241.
17. Daberkow D. P., Riedy M. D., Kesner R. P., and, Keefe K. A., (2008) Effect of methamphetamine neurotoxicity on learning-induced Arc mRNA expression in identified striatal efferent neurons. Neurotox. Res. 14, 307-315.
18. Daberkow D. P., Brown H. D., Bunner K. D., Kraniotis S. A., Doellman M. A., Ragozzino M. E., Garris P. A., and, Roitman M. F., (2013) Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J. Neurosci. 33, 452-463.
19. Dean A. C., Groman S. M., Morales A. M., and, London E. D., (2013) An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology 38, 259-274.
20. Dreyer J. K., Herrik K. F., Berg R. W., and, Hounsgaard J. D., (2010) Influence of phasic and tonic dopamine release on receptor activation. J. Neurosci. 30, 14273-14283.
21. Frank M. J., Seeberger L. C., and, O'reilly R. C., (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306, 1940-1943.
22. Fu L., and, Beckstead R. M., (1992) Cortical stimulation induces fos expression in striatal neurons. Neuroscience 46, 329-334.
23. Ganguly A., and, Keefe K. A., (2000) Effects of MK-801 on D1 dopamine receptor-mediated immediate early gene expression in the dopamine-depleted striatum. Brain Res. 871, 156-159.
24. Ganguly A., and, Keefe K. A., (2001) Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons. Neuroscience 103, 405-412.
25. Garris P. A., Ciolkowski E. L., Pastore P., and, Wightman R. M., (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14, 6084-6093.
26. Gerfen C. R., and, Surmeier D. J., (2011) Modulation of striatal projection systems by dopamine. Annu. Rev. Neurosci. 34, 441-466.
27. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J. Jr, and, Sibley D. R., (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432.
28. Gerfen C. R., McGinty J. F., and, Young W. S. III, (1991) Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11, 1016-1031.
29. Gonon F., (1997) Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J. Neurosci. 17, 5972-5978.
30. Guthrie M., Myers C. E., and, Gluck M. A., (2009) A neurocomputational model of tonic and phasic dopamine in action selection: a comparison with cognitive deficits in Parkinson's disease. Behav. Brain Res. 200, 48-59.
31. Hart C. L., Marvin C. B., Silver R., and, Smith E. E., (2012) Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology 37, 586-608.
32. Herring N. R., Schaefer T. L., Gudelsky G. A., Vorhees C. V., and, Williams M. T., (2008) Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology 199, 637-650.
33. Horner K. A., Adams D. H., Hanson G. R., and, Keefe K. A., (2005) Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion. Neuroscience 131, 67-77.
34. Hornykiewicz O., and, Kish S. J., (1987) Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45, 19-34.
35. Hotchkiss A. J., and, Gibb J. W., (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214, 257-262.
36. Howard C. D., Keefe K. A., Garris P. A., and, Daberkow D. P., (2011) Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. J. Neurochem. 118, 668-676.
37. Izquierdo A., Belcher A. M., Scott L., Cazares V. A., Chen J., O'Dell S. J., Malvaez M., Wu T., and, Marshall J. F., (2010) Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine. Neuropsychopharmacology 35, 505-514.
38. Johnson-Davis K. L., Hanson G. R., and, Keefe K. A., (2002) Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression. J. Neurochem. 82, 1472-1479.
39. Keefe K. A., and, Adams A. C., (1998) Differential effects of N-methyl-D-aspartate receptor blockade on eticlopride-induced immediate early gene expression in the medial and lateral striatum. J. Pharmacol. Exp. Ther. 287, 1076-1083.
40. Keefe K. A., and, Ganguly A., (1998) Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: evidence for involvement of pharmacologically distinct NMDA receptors? Dev. Neurosci. 20, 216-228.
41. Le Moine C., Normand E., Guitteny A. F., Fouque B., Teoule R., and, Bloch B., (1990) Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl Acad. Sci. USA 87, 230-234.
42. Liste I., Rozas G., Guerra M. J., and, Labandeira-Garcia J. L., (1995) Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Brain Res. 700, 1-12.
43. Logman M. J., Budygin E. A., Gainetdinov R. R., and, Wightman R. M., (2000) Quantitation of in vivo measurements with carbon fiber microelectrodes. J. Neurosci. Methods 95, 95-102.
44. Marshall J. F., Belcher A. M., Feinstein E. M., and, O'Dell S. J., (2007) Methamphetamine-induced neural and cognitive changes in rodents. Addiction 102 (Suppl 1), 61-69.
45. McGeorge A. J., and, Faull R. L., (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29, 503-537.
46. Nieuwenhuys R., Geeraedts L. M., and, Veening J. G., (1982) The medial forebrain bundle of the rat. I. General introduction. J. Comp. Neurol. 206, 49-81.
47. Nisbet A. P., Foster O. J., Kingsbury A., Eve D. J., Daniel S. E., Marsden C. D., and, Lees A. J., (1995) Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease. Neuroscience 66, 361-376.
48. Nisenbaum L. K., Crowley W. R., and, Kitai S. T., (1996) Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Brain Res. Mol. Brain Res. 37, 209-216.
49. O'Dell S. J., Feinberg L. M., and, Marshall J. F., (2011) A neurotoxic regimen of methamphetamine impairs novelty recognition as measured by a social odor-based task. Behav. Brain Res. 216, 396-401.
50. Onn S. P., West A. R., and, Grace A. A., (2000) Dopamine-mediated regulation of striatal neuronal and network interactions. Trends Neurosci. 23, S48-S56.
51. Packard M. G., and, Knowlton B. J., (2002) Learning and memory functions of the basal ganglia. Annu. Rev. Neurosci. 25, 563-593.
52. Parthasarathy H. B., and, Graybiel A. M., (1997) Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J. Neurosci. 17, 2477-2491.
53. Pastuzyn E. D., Chapman D. E., Wilcox K. S., and, Keefe K. A., (2012) Altered learning and Arc-regulated consolidation of learning in striatum by methamphetamine-induced neurotoxicity. Neuropsychopharmacology 37, 885-895.
54. Paxinos G., and, Watson C., (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
55. Pothos E., Desmond M., and, Sulzer D., (1996) L-3,4- dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro. J. Neurochem. 66, 629-636.
56. Ramanathan S., Hanley J. J., Deniau J. M., and, Bolam J. P., (2002) Synaptic convergence of motor and somatosensory cortical afferents onto GABAergic interneurons in the rat striatum. J. Neurosci. 22, 8158-8169.
57. Ramsson E. S., Howard C. D., Covey D. P., and, Garris P. A., (2011) High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. J. Neurochem. 119, 1162-1172.
58. Ricaurte G. A., Schuster C. R., and, Seiden L. S., (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193, 153-163.
59. Ricaurte G. A., Guillery R. W., Seiden L. S., Schuster C. R., and, Moore R. Y., (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235, 93-103.
60. Richfield E. K., Penney J. B., and, Young A. B., (1989) Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Neuroscience 30, 767-777.
61. Robinson T. E., Yew J., Paulson P. E., and, Camp D. M., (1990) The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum. Neurosci. Lett. 110, 193-198.
62. Rodriguez M., Morales I., Gonzalez-Mora J. L., Gomez I., Sabate M., Dopico J. G., Rodriguez-Oroz M. C., and, Obeso J. A., (2007) Different levodopa actions on the extracellular dopamine pools in the rat striatum. Synapse 61, 61-71.
63. Schroder N., O'Dell S. J., and, Marshall J. F., (2003) Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 49, 89-96.
64. Scott J. C., Woods S. P., Matt G. E., Meyer R. A., Heaton R. K., Atkinson J. H., and, Grant I., (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev. 17, 275-297.
65. Son J. H., Latimer C., and, Keefe K. A., (2011) Impaired formation of stimulus-response, but not action-outcome, associations in rats with methamphetamine-induced neurotoxicity. Neuropsychopharmacology 36, 2441-2451.
66. Steiner H., and, Van Waes V., (2013) Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants. Prog. Neurobiol. 100, 60-80.
67. Surmeier D. J., Song W. J., and, Yan Z., (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16, 6579-6591.
68. Volkow N. D., Chang L., Wang G. J., et al,. (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158, 377-382.
69. Westin J. E., Andersson M., Lundblad M., and, Cenci M. A., (2001) Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease. Eur. J. Neurosci. 14, 1171-1176.
70. Wiecki T. V., and, Frank M. J., (2010) Neurocomputational models of motor and cognitive deficits in Parkinson's disease. Prog. Brain Res. 183, 275-297.
71. Wilson J. M., Kalasinsky K. S., Levey A. I., Bergeron C., Reiber G., Anthony R. M., Schmunk G. A., Shannak K., Haycock J. W., and, Kish S. J., (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2, 699-703.
72. Zeng B. Y., Jolkkonen J., Jenner P., and, Marsden C. D., (1995) Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat. Neuroscience 66, 19-28.